De Novo designed peptides scavenge SARS-CoV2 Spike-protein
Implementing Organization
BITS Pilani - Hyderabad Campus, Telangana
Innovator Details
Innovator
Prof. Samit Chattopadhyay
Co-Developer / Co-Innovator
Dr. Subhrangsu Chatterjee, Associate Professor, Bose Institute, Kolkata
About
This project focuses on developing a peptide-based therapeutic targeting the Spike protein of SARS-CoV2. A lead molecule demonstrated 98% inhibition in patient-derived strains, stability in saliva, and safety in animal models. Designed for use as nasal drops or inhalers, it offers a low-cost, effective solution against COVID-19.
BITS Pilani - Hyderabad Campus, Telangana
Accessibility Controls